BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, June 11, 2026
Home » Authors » Anette Breindl

Anette Breindl

Articles

ARTICLES

Prêt-à-porter pancreas wearables tell all, do some

March 15, 2017
By Anette Breindl

Mutational signature approach could broaden PARP inhibitors’ reach

March 15, 2017
By Anette Breindl
Comprehensive analysis of mutational patterns has demonstrated that roughly 20 percent of breast tumors showed a mutational signature that was characteristic of BRCA mutations. Even without BRCA mutations, the mutational pattern suggests such tumors might have the same sensitivity to poly ADP-ribose polymerase (PARP) inhibitors as tumors with detectable BRCA mutations.
Read More

Bench Press: BioWorld looks at translational medicine

March 13, 2017
By Anette Breindl
Loss of the survival of motor neuron 1 (SMN1) gene causes spinal muscular atrophy (SMA), which leads to paralysis and ultimately death, and is currently the most frequent monogenic cause of infant mortality.
Read More

Dead blood cells kill autoimmune responses

March 10, 2017
By Anette Breindl
Engineered blood cells were able to alleviate and prevent symptoms of type I diabetes (T1D) and multiple sclerosis (MS), two of the more common autoimmune diseases, by inducing immune tolerance to antigens.
Read More

Repurposed drug helps antibiotics get under bacterial skin

March 8, 2017
By Anette Breindl
Pentamidine, an antiparasitic drug that is on the World Health Organization's (WHO) list of essential medicines and is used to treat conditions including leishmaniasis and pneumocystis pneumonia, sensitized gram-negative bacteria to antibiotics that are usually effective only for treating gram-positive bugs, including bacterial strains that were resistant to colistin.
Read More

Act of sequencing damages DNA

March 6, 2017
By Anette Breindl
Even in fresh, high-quality DNA samples, the act of sequencing itself induced DNA damage at a frequency comparable to that of rare mutations occurring, potentially confounding the identification of rare variants.
Read More

Bench Press: BioWorld looks at translational medicine

March 6, 2017
By Anette Breindl
Different platinum-based chemotherapies differed in their mechanisms of action, opening the door to rational combinations with other therapies.
Read More

Working on a 'Lipinski's rule' for antibodies

March 3, 2017
By Anette Breindl

Lipinski's rule of fives is a rule of thumb to predict whether a small-molecule lead is more likely to end up a drug or a dud, based on its pharmacological and biological properties.


Read More

Heart warming study could alleviate organ shortage

March 2, 2017
By Anette Breindl

Heart warming study could alleviate organ shortage

March 2, 2017
By Anette Breindl
Silica-coated iron oxide nanoparticles that can be used for the rapid warming of frozen tissues could pave the way for cryopreservation of organs, if the warming method can be scaled up sufficiently. Researchers from the University of Minnesota, Clemson University and Tissue Testing Technologies LLC, published their findings in the March 1, 2017, issue of Science Translational Medicine.
Read More
View All Articles by Anette Breindl

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 10, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 9, 2026
  • 3D rendering of β2-Adrenergic receptor GPCR protein molecule embedded in lipid bilayer membrane.

    Skape Bio unlocks GPCR targets with de novo-designed miniproteins

    BioWorld
    Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
  • Wuxi Apptec signage

    Wuxi Apptec insists it’s ‘not a Chinese military company’

    BioWorld
    Wuxi Apptec isn’t going down without a fight after the U.S. Department of Defense added it to the Section 1260H list June 8 as a designated “Chinese military...
  • Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors

    BioWorld Science
    Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing